SV Investment Corporation (289080) - Total Liabilities

Latest as of June 2026: ₩14.72 Billion KRW ≈ $9.98 Million USD

Based on the latest financial reports, SV Investment Corporation (289080) has total liabilities worth ₩14.72 Billion KRW (≈ $9.98 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SV Investment Corporation (289080) asset resilience to evaluate the company's liquid asset resilience ratio.

SV Investment Corporation - Total Liabilities Trend (2016–2025)

This chart illustrates how SV Investment Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is SV Investment Corporation's balance sheet.

SV Investment Corporation Competitors by Total Liabilities

The table below lists competitors of SV Investment Corporation ranked by their total liabilities.

Company Country Total Liabilities
Haitai Confectionery and Foods Co Ltd
KO:101530
Korea ₩417.45 Billion
Bank Victoria International
JK:BVIC
Indonesia Rp29.96 Trillion
SD Standard Drilling PLC
OL:SDSD
Norway Nkr923.00K
Indo Amines Limited
NSE:INDOAMIN
India Rs4.83 Billion
Suraj Estate Developers Ltd.
NSE:SURAJEST
India Rs9.68 Billion
Kencana Agri Limited
F:KEBA
Germany €206.68 Million
Clover Corporation Ltd
AU:CLV
Australia AU$14.57 Million
Jeil Pharmaceutical Co Ltd
KO:271980
Korea ₩272.85 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down SV Investment Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is SV Investment Corporation's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.23 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SV Investment Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SV Investment Corporation (2016–2025)

The table below shows the annual total liabilities of SV Investment Corporation from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 ₩22.75 Billion
≈ $15.42 Million
+3.27%
2024-12-31 ₩22.03 Billion
≈ $14.93 Million
+10.07%
2023-12-31 ₩20.02 Billion
≈ $13.57 Million
+175.99%
2022-12-31 ₩7.25 Billion
≈ $4.92 Million
-24.17%
2021-12-31 ₩9.57 Billion
≈ $6.48 Million
-33.92%
2020-12-31 ₩14.48 Billion
≈ $9.81 Million
+124.44%
2019-12-31 ₩6.45 Billion
≈ $4.37 Million
-22.37%
2018-12-31 ₩8.31 Billion
≈ $5.63 Million
-21.59%
2017-12-31 ₩10.60 Billion
≈ $7.18 Million
+5.90%
2016-12-31 ₩10.00 Billion
≈ $6.78 Million
--

About SV Investment Corporation

KQ:289080 Korea Asset Management
Market Cap
$99.33 Million
₩146.57 Billion KRW
Market Cap Rank
#19315 Global
#954 in Korea
Share Price
₩2700.00
Change (1 day)
+1.69%
52-Week Range
₩1517.00 - ₩4550.00
All Time High
₩7624.04
About

SV Investment Corporation is a private equity and venture capital firm. It considers investments in companies at early, mid, and late venture stages and private investments in public equities. The firm specializes in growth capital and buyouts. It also considers investments in healthcare, biotechnology, biopharmaceutical, cultural entertainment, technology, media, telecommunications, information … Read more